Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|December 30, 2025
Newborn Screening in Fabry DiseaseMarta Olszewska, Krzysztof Schwermer, Krzysztof Pawlaczyk
International Journal of Nephrology and Renovascular Disease|October 23, 2023
Benefits of Preserving Residual Urine Output in Patients Undergoing Maintenance HaemodialysisMikołaj Dopierała, Krzysztof Schwermer, Krzysztof Hoppe, et al.
Case Reports in Nephrology|February 22, 2014
Acute Progression of Adult-Onset Atypical Hemolytic-Uremic Syndrome due to CFH Mutation: A Case ReportBartlomiej Posnik, Dorota Sikorska, Krzysztof Hoppe, et al.
Biomed Research International|August 4, 2015
Animal Models of Peritoneal Dialysis: Thirty Years of Our Own ExperienceKrzysztof Pawlaczyk, Ewa Baum, Krzysztof Schwermer, et al.
Biomedicines|June 26, 2025
New and Emerging Biomarkers in Chronic Kidney DiseaseMikołaj Dopierała, Nadja Nitz, Oliwia Król, et al.
Polskie Archiwum Medycyny Wewnetrznej|July 26, 2016
Adropin and irisin levels in relation to nutrition, body composition, and insulin resistance in patients with end-stage renal disease on chronic hemodialysis and peritoneal dialysisMałgorzata Kałużna, Krzysztof Hoppe, Krzysztof Schwermer, et al.
Thescientificworldjournal|March 28, 2014
The polymorphism of the ACE gene affects left ventricular hypertrophy and causes disturbances in left ventricular systolic/diastolic function in patients with autosomal dominant polycystic kidney diseaseMaria Wanic-Kossowska, Bartlomiej Posnik, Mikolaj Kobelski, et al.
Polish Archives of Internal Medicine|August 5, 2021
Overhydration as a modifiable cardiovascular risk factor in patients undergoing hemodialysisKrzysztof Schwermer, Krzysztof Hoppe, Małgorzata Kałużna, et al.
Nutrients|January 21, 2022
Can Overnutrition Lead to Wasting?-The Paradox of Diabetes Mellitus in End-Stage Renal Disease Treated with Maintenance HemodialysisKrzysztof Hoppe, Krzysztof Schwermer, Mikołaj Dopierała, et al.
Life (Basel, Switzerland)|April 30, 2021
Is Preptin a New Bone Metabolism Parameter in Hemodialysis Patients?Małgorzata Kałużna, Krzysztof Pawlaczyk, Krzysztof Schwermer, et al.
Pageof 2